Colony Group’s NanoViricides NNVC Stock Holding History

Colony Group’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-4,286	Closed	-$569K	–	898
2015 Q2	$569K	Hold	4,286	–	–	0.06%	253
2015 Q1	$569K	Buy	+4,286	New	+$229K	0.06%	208
2014 Q4	–	Sell	-4,648	Closed	-$1.3M	–	820
2014 Q3	$1.3M	Buy	4,648 +362	+8%	+$28.4K	0.15%	130
2014 Q2	$569K	Sell	4,286 -2,857	-40%	-$203K	0.08%	155
2014 Q1	$949K	Hold	7,143	–	–	0.13%	125
2013 Q4	$949K	Buy	+7,143	New	+$735K	0.13%	118

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SIP

Stoneridge Investment Partners Radnor, Pennsylvania $138M AUM 7.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Colony Group's NNVC Position: Q3 2015 in Review

Colony Group sold out of NanoViricides (NNVC) in Q3 2015, closing a stake of 4,286 shares — an estimated $569K sold.

Colony Group first reported a position in NNVC in Q4 2013 and held it in 6 quarters. The position peaked at $1.3M in Q3 2014. 45 funds tracked by Wall St. Rank hold NNVC as of Q3 2015.

Colony Group reported no remaining NanoViricides position as of Q3 2015 after selling out during the quarter.
Colony Group sold 4,286 NanoViricides shares in Q3 2015, an estimated $569K.
Colony Group first reported a position in NanoViricides in Q4 2013 and held it in 6 quarters.
Colony Group's NanoViricides position peaked at $1.3M in Q3 2014.
45 funds tracked by Wall St. Rank held NanoViricides as of Q3 2015.

Based on Colony Group's 13F filing for Q3 2015, filed 16 Nov 2015.